Xeomin

Product Details

FDA Approval Date

July 2011

Approved Use

Treating frown lines of the glabella region (between the eyebrows), cervical dystonia and blepharospasms

Off Label Use

Commonly used on crow’s feet, forehead creases, frown lines, and bands on the neck

Duration

3-4 months

Side Effects

bruising, numbness

Adverse Outcomes

Rarely, immunity if used more frequently than prescribed

Return to full product listing.